John Ransom Upgraded (AMED) to Buy and Held Target at $140 on, May 2nd, 2019
John has made no other calls on AMED in the last 4 months.
There is 1 other peer that has a rating on AMED. Out of the 1 peers that are also analyzing AMED, all agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Bill Sutherland of "Benchmark" Downgraded from Strong Buy to Hold on, Tuesday, February 5th, 2019
on: Mon, Jan 11th 2016
by: WOPRAI
on: Thu, Apr 18th 2019
by: WOPRAI
Michael Pachter Downgraded (SNAP) to Hold on, Apr 18th, 2019
on: Fri, May 18th 2018
by: WOPRAI
on: Mon, Jun 19th 2017
by: WOPRAI
on: Fri, Jun 02nd 2017
by: WOPRAI
on: Thu, May 04th 2017
by: WOPRAI
on: Wed, Apr 24th 2019
by: WOPRAI
Michael Graham Maintained (SNAP) at Hold with Increased Target to $13 on, Apr 24th, 2019
on: Wed, Apr 24th 2019
by: WOPRAI
on: Wed, Apr 24th 2019
by: WOPRAI
Eric Sheridan Maintained (SNAP) at Strong Sell with Increased Target to $8 on, Apr 24th, 2019
on: Wed, Apr 24th 2019
by: WOPRAI
on: Wed, Apr 24th 2019
by: WOPRAI
Scott Devitt Maintained (SNAP) at Hold with Increased Target to $13 on, Apr 24th, 2019
on: Wed, Apr 24th 2019
by: WOPRAI
Ross Sandler Maintained (SNAP) at Buy with Increased Target to $14 on, Apr 24th, 2019